Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Clinical Trials in China / NCT06903364
Recruiting Observational

Association of Lifestyle With Complications in the Diabetic Population

NCT06903364 · tracked via the Priya Life Science China tracker
Sponsor
Nanfang Hospital, Southern Medical University
Phase
Observational
Started
2024-08-01
Last updated
2026-04-08

Condition(s) studied

Diabetes Mellitus

Study summary

This study is a prospective study of patients with diabetes. The main objective of this study is to investigate the relationship between lifestyle and long-term complications in diabetic patients, which will help to screen out the high-risk group at an early stage and provide scientific advice for the prevention of complications in diabetic patients.

Eligibility

Sex
ALL
Min age
20 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: 1. Patients with a normative diagnosis of type 2 diabetes 2. Age ≥20 years old, regardless of gender 3. From January 2022 to December 2025, he was treated in Nanfang Hospital Exclusion Criteria: 1. In the acute infection phase 2. The researchers judged that it was not suitable to participate in this study

Primary outcome measure(s)

  • Number of Participants with Diabetes Complications — From enrollment to the end of the three-year follow-up

Trial sites (1)

FacilityCityRegionStatus
NanFang Hospital of Southern Medical University Guangzhou China Recruiting

More Nanfang Hospital, Southern Medical University trials in China

Immune Dynamics in the Natural History of Chronic HBV Infection Recruiting
Anterior Segment Anatomy Assessed by Swept-Source OCT in Ocular Surgery Patients Recruiting
Correlation and Predictive Research of Metal Elements in Radiation-Induced Oral Mucositis Recruiting
Study of Peripheral Blood CHI3L1 to Predict Tumor Response to Radiotherapy Starting soon
Dynamic Functional Imaging Phenotyping and Disease Progression Risk Assessment in COPD Using Dynamic Chest Radiography: A Multicenter Retrospective Study Recruiting

Other trials for the same condition

Effect of CGM on Glucose Control in Non-insulin-treated Patients With Type 2 Diabetes Mellitus Active, not recruiting
Clinical Study on the Safety and Efficacy of Immunophenotyped Pancreatic Endocrine Organoid Bank in Treating Patients With T3c Diabetes Active, not recruiting
Assessing Diabetic Foot Ulcer Microcirculation With High-frequency Contrast Enhanced Ultrasound Starting soon
A Study to Evaluate ENERGI-F703 GEL in Diabetic Foot Ulcer Recruiting
Multicenter RCT of Eye-Brain Imaging in Diabetes Neurovascular Coupling Starting soon
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06903364 on ClinicalTrials.gov ↗ ← All trials in China